|
Haas et al. (2020) [14]
|
Number of mature oocytes; total number of oocytes, 2PN zygotes, embryo number, clinical pregnancy rate, implantation rate, live birth rate
|
Number of mature oocytes
|
Ongoing pregnancy rate
|
Number of mature oocytes: number of MII oocytes. Other outcomes were not defined.
|
|
Mahajan et al. (2016) [21]
|
Number of mature oocytes; total number of oocytes, 2PN zygotes; usable embryos
|
Number of mature oocytes; usable embryos
|
Ongoing pregnancy rate, clinical pregnancy rate, implantation rate, live birth rate
|
Usable embryos: embryos good for transfer and cryopreservation. Other outcomes were not defined.
|
|
Ali et al. (2020) [13]
|
Number of mature oocytes; total number of oocytes; number of Grade 1 embryos; fertilization rate (without the exact fertilizaton number); implantation rate (without the exact sac number and transferred embryo number); clinical pregnancy rate; live birth rate
|
Number of mature oocytes
|
Ongoing pregnancy rate
|
Number of mature oocytes: number of MII oocytes; fertilization rate: the number of the fertilized oocytes divided by the total number of the retrieved oocytes per 100; implantation rate: total number of the sacs divided by the total number of the transferred embryos per 100; clinical pregnancy rate: the number of the cases with at least one sac in or out the uterus divided by the cycles initiated per 100; live birth rate: total number of the cases with at least one baby born after 24 weeks of gestation divided by the total number of the cycles initiated per 100.
|
|
Schachter et al. (2008) [24]
|
Total number of oocytes; usable embryos; ongoing pregnancy rate; clinical pregnancy rate; implantation rate
|
Not mentioned
|
Number of mature oocytes; 2PN zygotes; live birth rate
|
Implantation rate: number of gestational sacs per embryo transferred. Other outcomes were not defined.
|
|
Haas et al. (2019) [19]
|
Total number of oocytes; 2PN zygotes; ongoing pregnancy rate
|
Total number of oocytes, top-quality embryo
|
Number of mature oocytes, clinical pregnancy rate, implantation rate, live birth rate, usable embryos
|
Ongoing pregnancy: visualization of a gestational sac and fetal cardiac activity on transvaginal ultrasound. Other outcomes were not defined.
|
|
Eftekhar et al. (2017) [20]
|
Number of mature oocytes; total number of oocytes, usable embryos; implantation number, clinical and ongoing pregnancy
|
Clinical pregnancy
|
2PN zygotes, live birth rate
|
No definition of outcomes
|
|
Kim et al. (2014) [22]
|
Number of mature oocytes; total number of oocytes, 2PN zygotes, top-quality embryo, clinical pregnancy, implantation rate, live birth rate, severe OHSS
|
Not mentioned
|
Ongoing pregnancy rate, usable embryos
|
Clinical pregnancy: increased serum β-hCG concentration. Other outcomes were not defined.
|
|
Decleer et al. (2014) [23]
|
Number of mature oocytes; total number of oocytes, 2PN zygotes; Implantation rate; ongoing pregnancy rate
|
Number of mature oocytes
|
Clinical pregnancy rate, live birth rate, usable embryos
|
Number of mature oocytes: number of MII oocytes. Implantation rate: mean number of foetal sacs per embryo transferred. Ongoing pregnancy: confirmed by ultrasound 23 days after embryo transfer. Other outcomes were not defined.
|
